Skip to main content
logo
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
155.35
-2.42 (-1.53%)
Aug 10, 2026, 10:43 AM EDT - Market open

Palvella Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----31.42
Revenue Growth
-----7.14%
Gross Profit
-----31.42
Operating Income
-57.74-38.6-14.1-11.87-69.38-51.83
Net Income
-11.35-41.72-17.4317.92-33.28-45.74
Earnings Per Share
-4.83-3.71-7.832.17-4.82-56.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
250.5857.9883.67.3559.17117.76
Total Debt
0.540.630013.113.84
Net Cash (Debt)
250.0557.3583.67.3546.07103.92
Net Cash Growth
255.02%-31.40%1037.44%-84.05%-55.67%90.67%
Net Cash Per Share
19.855.1037.564.1025.68128.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2016
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '16
Operating Cash Flow
-36.51-25.01-10.84-13.7-59.93-14.39
Capital Expenditures
-----1.04-0.58
Free Cash Flow
-36.51-25.01-10.84-13.7-60.97-14.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------164.97%
Pretax Margin
------145.58%
Profit Margin
------145.58%
FCF Margin
-----0.00%

Valuation
Selected indicators aren't available for this stock.